Active skin care in the interrecurrent period in patients with acne
Abstract
An open, single-site, controlled, randomized clinical study on the effectiveness and safety of administration of a new locally produced topical cream with azelaic acid and organosilicon glycerhydrogel in acne patients during the interrecurrent period was performed. The undertaken study has shown that the new cream administration leads to positive dynamics of IGA and BASI, VAS of skin oiliness and the quality of life before and after the cream administration. The results of the study make it possible to recommend the new cream for administration during acne interrecurrent period as an alternative to standard skin-care products.
About the Authors
N. V. Zilberberg
ГБУ СО УрНИИДВиИ
Russian Federation
Russian Federation
M. M. Kohan
ГБУ СО УрНИИДВиИ
Russian Federation
Russian Federation
A. I. Polishchuk
ГБУ СО УрНИИДВиИ
Russian Federation
Russian Federation
T. G. Honina
ФГБУН ИОС им. И. Я. Постовского Уральского отделения РАН
Russian Federation
Russian Federation
References
1. Федеральные клинические рекомендации. Дерматовенерология 2015. Российское общество дерматовенерологов и косметологов. М., 2015.
2. Richter C. et al. Sensitivity to change of the Dermatology Life Quality Index in adult females with facial acne vulgaris: a validation study // JEADV. 2017. 31. P. 169–174.
3. Tan J. K., Bhate K. A global perspective on the epidemiology of acne // Br J Dermatol. 2015. 1. P. 3–12.
4. Кунгуров Н. В., Кохан М. М., Шабардина О. В. Опыт использования нового препарата азелаиновой кислоты — геля скинорен — в терапии угревой сыпи // Клиническая дерматология и венерология. 2005. № 1. С. 31–36.
5. Zaenglein et al. Guidelines of care for the management of acne vulgaris // J Am Acad Dermatol. 2016. 74. P. 945–73.
6. Dressler C., Rosumeck S., Nast A. How Much Do We Know about Maintaining Treatment Response after Successful Acne Therapy? Systematic Review on the Efficacy and Safety of Acne Maintenance Therapy // Dermatology. 2016. 232. P. 371–380.
7. Rocha M., Sanudo A., Bagatin E. The effect on acne quality of life of topical azelaic acid 15% gel versus a combined oral contraceptive in adult female acne: A randomized trial // Dermatoendocrinology. 2018. 9. 1. P. 1–4.
8. Chernyshov P. V. et al. Quality of life measurement in acne. Position Paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes and Acne, Rosacea and Hidradenitis Suppurativa // JEADV. 2018. 32. P. 194–208.
9. Перламутров Ю. Н. et al. Эффективность и переносимость терапии акне с использованием системного изотретиноина // Вестник дерматологии и венерологии. Фармакология в дерматовенерологии — 2015. 5. С. 128–133.
10. Plewig G., Kligman A. M. ACNE and ROSACEA. Springer Science & Business Media. 2012. P. 270.
11. Thiboutot D. et al. New insights into the management of acne: an update from the Global Alliance to Improve Outcomes in Acne group // J Am Acad Dermatol. 2009. 60. P. S1–S50.
12. Hayashi N., Miyachi Y., Kawashima M. Prevalence of scars and ‘mini-scars’, and their impact on quality of life in Japanese patients with acne // J Dermatol. 2015. 42. P. 690–696.
13. Gollnick H. P. et al. A consensus-based practical and daily guide for the treatment of acne patients // JEADV. 2016. 30. P. 1480–1490.
14. Nast A. et al. European evidence-based (S3) guideline for the treatment of acne — update 2016 // JEADV. 2016.
15. Thielitz A. et al. A randomized investigator-blind parallel-group study to assess efficacy and safety of azelaic acid 15% gel vs. adapalene 0.1% gel in the treatment and maintenance treatment of female adult acne // J Eur Acad Dermatol Venereol. 2015. 29. P. 789–796.
16. Rulcova J. Azelaic acid in the treatment of acne vulgaris // Cesko-Slovenska Dermatologie. 2001. № 76. P. 21–24.
17. Ozkan M. et al. Clinical efficacy of topical clindamycin phosphate and azelaic acid of acne vulgaris and emergence of resistant coagulase-negative staphylococci // Turkish Journal of Medical Sciences. 2000. Vol. 30, Iss. 5. P. 483–487.
18. Worret W. I., Fluhr J. W. Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid // J Dtsch Dermatol Ges. 2006. Vol. 4, № 4. P. 293–300.
19. Burchacka E., Potaczek P., Paduszynski P., Karlowicz-Bodalska K., Han T., Han S. New effective azelaic acid liposomal gel formulation of enhanced pharmaceutical bioavailability // Biomed Pharmacother. 2016. 83. P. 771–775.
20. Al-Marabeh S. et al. A prodrug approach to enhance azelaic acid percutaneous availability // Pharm Dev Technol. 2017. 22 (4). P. 578–586.
21. Хонина T. Г. и др. // Pharm. Chem. J. (Engl. Transl.). 2008. 11 (42). 609.
22. Патент № 2255939 РФ. Глицераты кремния, обладающие транскутанной проводимостью медикаментозных средств, и глицерогидрогели на их основе / Хонина Т. Г. и соавт.; заявитель и патенообладатель Ин-т орг. синтеза УрО РАН. № 2003124688/04; заявл. 07.08.2003; опубл. 10.07.2005, Бюл. № 19.
23. Fabbrocini G. et al. Fragility of epidermis: acne and post-procedure lesional skin // JEADV. 2017. 31 (6). P. 3–18.
24. Plewig G., Kligman A. M. ACNE and ROSACEA. Springer Science & Business Media, 2012. P. 270.
25. Lid?n S., G?ransson K., Odsell L. Clinical evaluation in acne // Acta Derm Venereol. 1980. 89. P. 47–52.
26. Lehmann H. P. et al. Acne Therapy: A Methodologic Review // J Am Acad of Dermatol. 2002. 47. P. 231–240.
27. Motley R. J., Finlay A. Y. Practical use of a disability index in the routine management of acne // Clin exp Dermatol. 1992. 17. P. 1–3.
Review
For citations:
Zilberberg N.V., Kohan M.M., Polishchuk A.I., Honina T.G. Active skin care in the interrecurrent period in patients with acne. Lechaschi Vrach. 2018;(11):27. (In Russ.)
Views:
242
JATS XML
Email this article 
